In its later stages, prostatitis can lead to benign prostatic hyperplasia (BPH). Prostatitis refers to inflammation of the prostate gland, while BPH refers to an enlarged prostate. If prostatitis is not treated promptly, the prolonged inflammation can lead to fibrosis of the prostate tissue, thereby causing the prostate to enlarge.
The mechanism by which prostatitis leads to benign prostatic hyperplasia (BPH) in its later stages is mainly related to the long-term presence of inflammation. Prostatitis is caused by bacterial infection, leading to an inflammatory response in the prostate tissue. If the inflammation persists, the prostate tissue may undergo fibrosis, resulting in an enlarged prostate. Prostatitis can also cause hyperplasia of the prostate tissue, further leading to BPH. BPH not only affects the patient's urinary function but may also cause other complications, such as urinary retention and urethral obstruction.
The risks and misconceptions surrounding prostatitis leading to benign prostatic hyperplasia (BPH) in its later stages need to be taken seriously. Prostatitis requires timely and thorough treatment; otherwise, prolonged inflammation may lead to fibrosis and hyperplasia of the prostate tissue, resulting in BPH. BPH not only affects urinary function but can also cause other complications such as urinary retention and urethral obstruction. Patients with prostatitis should seek medical attention promptly and receive standardized treatment to prevent BPH. Regular prostate-related examinations are also essential for early detection and management of prostatitis, reducing the risk of BPH.
[Management Tip:]
1. Seek medical attention promptly and receive standardized treatment for prostatitis.
2. Have regular prostate-related examinations to monitor prostate health.
3. Adjust your lifestyle and avoid bad habits such as prolonged sitting and holding in urine.
